Schedule 1, the indie drug-dealing simulator that took over the Steam charts, is reportedly under investigation over alleged copyright infringement.
For the past few weeks, big releases like Monster Hunter Wilds, Assassin’s Creed Shadows, and Split Fiction have been keeping players busy. That was initially the case before the indie simulation title Schedule 1 took over and became one of the most played games thus far in 2025.
Even two weeks after its early access release, the drug-dealing simulation title is still gaining insane momentum with a massive player count, as seen on SteamDB.
While it’s all been on the upswing, Schedule 1 is now facing its first big hurdle. As spotted by InsiderGaming, it appears that the game is now under investigation for possible copyright infringement.
Schedule 1 is under investigation for “potential infringement” of Movie Games S.A’s IP
Schedule 1 has been a huge hit, but it now faces alleged copyright infringement.
Developed by solo developer TVGS, the premise of Schedule 1 involves crafting and selling a plethora of different drugs, which you can then mix with different ingredients for some wacky effects, such as Anti-Gravity and even explosives, among others.
Although it’s been instantly met with massive success despite still being in early access, it has also attracted the attention of Movie Games S.A, which has its own series of drug-dealing simulation games.
On April 3, 2025, the publisher demanded Schedule 1 to be investigated, as seen in a document titled: “MOVIE GAMES SA (17/2025) Decision to commence investigation against the creators of the Schedule 1 production for claims regarding the infringement of the Issuer’s IP and related to committing an act of unfair competition against it.”
According to the document, “Potential infringement of the Issuer’s intellectual property rights and activities that may bear the characteristics of unfair competition have been identified.”
As reported by InsiderGaming, the investigation began on March 24, when Schedule 1 was released. This was followed with a “comparative analysis” of the company’s IP including the Drug Dealer simulator games as well as Schedule 1.
As for details of the investigation itself, it’s mentioned that they’re looking into “Elements of the game’s plot, mechanics, as well as UI – User Interface.”
The creator of Schedule 1 has yet to respond at the time of writing – though that hasn’t stopped fans from fighting back.
Drug Dealer Simulator currently has an “Overwhelmingly Negative” review on Steam as angry and disappointed players have review bombed games from the rival studio in light of their investigation.
Source link
